Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    plecanatide
Show Display Options
Rank Status Study
1 Active, not recruiting 12-Week Study of Plecanatide for CIC (The CIC3 Study)
Condition: Chronic Idiopathic Constipation
Interventions: Drug: Plecanatide;   Drug: Placebo
2 Active, not recruiting 12-Week Study of Plecanatide for CIC (The National CIC3 Study)
Condition: Chronic Idiopathic Constipation
Interventions: Drug: Plecanatide;   Drug: Placebo
3 Completed The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Condition: Chronic Idiopathic Constipation
Intervention: Drug: plecanatide
4 Active, not recruiting Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Condition: Chronic Idiopathic Constipation
Intervention: Drug: Plecanatide
5 Completed The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Condition: Irritable Bowel Syndrome Characterized by Constipation
Interventions: Drug: Plecanatide;   Drug: Placebo

Indicates status has not been verified in more than two years